Calcium Chloride

Active ingredient: Calcium Chloride

In short: Calcium Chloride Injection is indicated for the treatment of adult and pediatric patients with acute symptomatic hypocalcemia. Limitations of Use The safety and effectiveness of Calcium Chloride Injection for long-term use has not been established.

Forms & strengthsCalcium Chloride Injection, USP (single-dose) supplied as: • 10% (1,000 mg/10 mL) (100 mg/mL) in an Ansyr® Plastic Syringe• 10% (1,000 mg/10 mL) (100 mg/mL) in a LifeShield® Abboject® Glass SyringeThe 100 mg/mL concentration represents 27 mg or 1.4 mEq of …
LabelHenry Schein, Inc.
Label updatedOct 29, 2026

What is Calcium Chloride used for?

Calcium Chloride Injection is indicated for the treatment of adult and pediatric patients with acute symptomatic hypocalcemia.

Limitations of Use

The safety and effectiveness of Calcium Chloride Injection for long-term use has not been established.

Calcium Chloride dosage

2.1 Important Administration Instructions

Administer Calcium Chloride Injection by slow intravenous infusion in a central or deep vein in adults and pediatric patients (with or without renal impairment); do not administer by bolus . The maximum recommended infusion rate is 1 mL/minute (100 mg/minute).

Additional important administration instructions regarding Calcium Chloride Injection are as follows:

• Do not use intramuscularly or subcutaneously to avoid tissue necrosis calcinosis cutis .• Visually inspect for particulate matter and discoloration prior to administration (the solution is clear, and the seal is intact). Do not administer if the solution is unclear or the seal is not intact.• Stop the administration if the patient complains of any administration-related discomfort; administration may be resumed when symptoms disappear.• Discard the unused portion.• If time permits, allow the solution to warm to body temperature.

2.2 Recommended Dosage and Administration

The recommended dose range of Calcium Chloride Injection in:

• Adults is from 200 mg to 1,000 mg.• Pediatric patients is from 2.7 to 5 mg/kg of calcium chloride.

Dosing of this Calcium Chloride Injection product is not possible in patients who require doses less than 200 mg because the recommended dose cannot be achieved with the supplied syringe. For patients who require doses less than 200 mg, use another calcium chloride injection product that allows dosing of less than 200 mg.

Individualize the dose for a patient within these dose ranges depending on serum ionized calcium level, severity of hypocalcemia symptoms, and the acuity of hypocalcemia onset.

Repeated injections may be required because of rapid excretion of calcium.

2.3 Recommended Starting Dose in Patients with Renal Impairment

The recommended starting dose of Calcium Chloride Injection in :

• Adults with renal impairment is 200 mg.• Pediatric patients is 2.7 mg/kg of calcium chloride.

2.4 Drug Incompatibilities

Do not mix Calcium Chloride Injection with other drugs simultaneously. Do not mix Calcium Chloride Injection with ceftriaxone or administer these products simultaneously via a Y-site because concurrent use can lead to the formation of ceftriaxone-calcium precipitates :

• In neonates (28 days of age or younger), concomitant use of Calcium Chloride Injection and ceftriaxone is contraindicated .

• In patients older than 28 days of age, ceftriaxone and calcium-containing products may be administered sequentially, provided the infusion lines are thoroughly flushed between infusions with a compatible fluid.

How to take Calcium Chloride — instructions & advice from the label

Inform patients or caregivers of the following risks of Calcium Chloride Injection:

Arrhythmias with Concomitant Digoxin Use

Arrhythmias may occur if Calcium Chloride Injection and Digoxin are administered together .

Tissue Necrosis and Calcinosis

Administration of Calcium Chloride Injection may result in calcinosis cutis including tissue necrosis, ulceration, and secondary infection. .

Aluminum Toxicity

Calcium Chloride Injection contains aluminum that may be toxic .

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

Abboject® is a trademark of Abbott Laboratories

LifeShield® is the trademark of ICU Medical, Inc. and is used under license.

LAB-1022-4.0

Warnings & precautions

Do not take this medicine if: Calcium Chloride Injection is contraindicated in:

• Patients with ventricular fibrillation• Patients with asystole and electromechanical dissociation

Newborns (up to 28 days of age) if they require (or are expected to require) ceftriaxone intravenous treatment because of the risk of precipitation of ceftriaxone-calcium, regardless of whether these products would be received at different times or through separate intravenous lines .

5.1 End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates

The use of Calcium Chloride Injection is contraindicated in newborns (up to 28 days of age) if they require (or are expected to require) ceftriaxone intravenous treatment because of the risk of precipitation of ceftriaxone-calcium, regardless of whether these products would be received at different times or through separate intravenous lines . Cases of fatal reactions with calcium-ceftriaxone precipitates in lungs and kidneys in premature and full-term newborns aged less than 1 month have occurred when ceftriaxone and calcium were administered either simultaneously or non-simultaneously and through different intravenous lines. In-vitro studies demonstrated that neonates have an increased risk of precipitation of ceftriaxone-calcium compared to other age groups.

In patients older than 28 days of age, Calcium Chloride Injection and ceftriaxone intravenous solutions may be administered sequentially one after another if infusion lines at different sites are used, infusion lines are replaced, or infusion lines are thoroughly flushed between infusions with physiological salt solution to avoid precipitation. Do not mix or administer Calcium Chloride Injection simultaneously with ceftriaxone, even if using different infusion lines or different infusion sites as it can lead to precipitation of ceftriaxone-calcium . …

Calcium Chloride side effects

The following serious adverse reactions are also described elsewhere in the labeling:

• End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates • Hypotension, Bradycardia, Arrhythmias, and Syncope with Rapid Administration • Arrhythmias with Concomitant Digoxin Use • Tissue Necrosis and Calcinosis • Aluminum toxicity

The following adverse reactions have been identified in literature and postmarketing reports of calcium chloride. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure:

• Nervous system disorders: Paraesthesia (upon rapid injection), calcium taste• General disorders and administration site conditions: Sense of oppression, sense of “heat wave”, local burning sensation, injection site extravasation, injection site reactions• Cardiovascular disorders: Peripheral vasodilatation, decreased blood pressure

Drug interactions

7.1 Digoxin

Avoid the concomitant use of Calcium Chloride Injection with digoxin. If concomitant use is unavoidable, monitor ECG closely during administration of Calcium Chloride Injection.

Synergistic arrhythmias may occur with concomitant use. The use of Calcium Chloride Injection may result in hypercalcemia which increases the risk of digoxin toxicity .

7.2 Calcium Channel Blockers

Concomitant use of Calcium Chloride Injection and calcium channel blockers may reduce the response to calcium channel blockers. Avoid concomitant use. If concomitant use is unavoidable, monitor blood pressure closely during administration of Calcium Chloride Injection.

7.3 Drugs That Increase the Risk of Hypercalcemia

Increase frequency of monitoring of calcium concentrations in patients taking concomitant Calcium Chloride Injection and other drugs that increase the risk of hypercalcemia (e.g., calcipotriene, estrogen, lithium, parathyroid hormone, teriparatide, thiazide diuretics, Vitamin A, and Vitamin D).

About this medicine

10% Calcium Chloride Injection, USP is a sterile, nonpyrogenic, hypertonic solution for single administration only. Each mL contains 100 mg (1.4 mEq/mL) of calcium chloride, dihydrate (1.4 mEq each of Ca++ and Cl-) in water for injection. It is provided in a 10 mL single-dose syringe for intravenous injection. The solution contains no bacteriostat, antimicrobial agent or added buffer. The pH of 10% Calcium Chloride Injection, USP is 5.5 to 7.5 when diluted with water for injection to make a 5% solution. May contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The osmolar concentration is 2.04 mOsmol/mL (calc.). 10% Calcium Chloride Injection, USP is oxygen sensitive.

Calcium Chloride, USP dihydrate is chemically designated CaCl2 • 2H2O (dihydrate) and is described as white, odorless fragments or granules freely soluble in water.

Calcium Chloride Injection, USP contains no more than 1,000 mcg/L of aluminum .

How it works: 12.1 Mechanism of Action Intravenous administration of calcium chloride increases serum ionized calcium concentration. …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 0a3b8e0e-efb0-465b-84cb-d120b3096ebd. Read the full official label on DailyMed.